Nanobac Pharmaceuticals, Incorporated

NNBP · OTC
Analyze with AI
12/31/2007
9/30/2007
6/30/2007
3/31/2007
Operating Activities
Net Income-$1,167-$836-$717-$3,857
Dep. & Amort.$114$115$115$117
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$742$178$273$559
Other Non-Cash$337$1,468-$1,217$2,866
Operating Cash Flow-$110-$200-$285-$315
Investing Activities
PP&E Inv.$0$0$0-$2
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$0$0$0$50
Investing Cash Flow-$0-$3$0$52
Financing Activities
Debt Repay.$158$241$274$238
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$158$241$274$238
Forex Effect-$44-$38$5-$8
Net Chg. in Cash$3-$0-$5-$33
Supplemental Information
Beg. Cash$1$1$6$40
End Cash$4$1$1$6
Free Cash Flow-$110-$200-$285-$317